Consumer Division Divestments Would Spotlight Firms’ Value – Analysts
This article was originally published in The Tan Sheet
Germany’s Merck KGaA could join the ranks of firms like Pfizer potentially looking to leave the consumer health care product business, market analysts argue.
You may also be interested in...
Abbott Laboratories’ nutrition business – one of four divisions in the remaining diversified medical products firm – gains importance with the firm’s plan to spin off its research-based branded pharmaceuticals business.
Abbott Laboratories executives say its nutritionals business is staying put and can succeed without mergers and acquisitions, despite dragging U.S. sales.
Proposed appropriations cuts could threaten branded infant formulas’ strong competitive advantages.